Learn More
PURPOSE This phase III, double-blind, randomized, multicenter study evaluated the efficacy, pharmacodynamics, and safety of the oral aromatase inactivator exemestane (EXE) versus megestrol acetate(More)
PURPOSE To evaluate potential detrimental effects of exemestane on bone and lipid metabolism. PATIENTS AND METHODS Postmenopausal women with early breast cancer were randomly assigned to exemestane(More)